Search | IOVS | ARVO Journals

Showing 1 – 20 of 22

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Ultra-responders to faricimab: ≥4-step improvement in diabetic retinopathy severity in YOSEMITE/RHINE

Samir Narendra Patel; Michael Klufas; Jason Hsu; Alexandra Warter; Nicholas Dagincourt; Kara Gibson

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):3799.

ARVO Annual Meeting Abstract June 2024

Port Delivery System With Ranibizumab (PDS) in diabetic macular edema (DME): additional primary analysis results of the phase 3 Pagoda trial

Varun Malhotra; Michael A. Klufas; Dennis M Marcus; Jordan M Graff; Peter A Campochiaro; Salman Rahman; Paul Latkany; Shamika Gune; Stephanie DeGraaf; Ashwini Bobbala; Mel Rabena; Carlos Ruiz; Arshad M. Khanani

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6233.

ARVO Annual Meeting Abstract June 2023

Prevalence, Characteristics, and Outcomes of Retinal Detachment Associated with Toxoplasmosis Retinochoroiditis

Holden Caplan; Taku Wakabayashi; Michael Klufas; Sonia Mehta; Jordan Deaner; James P. Dunn; Yoshihiro Yonekawa

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4568.

ARVO Annual Meeting Abstract June 2023

Automated machine learning to predict anatomical outcomes in pneumatic retinopexy

Arina Nisanova; Arefeh Yavary; Jordan Deaner; Ferhina S. Ali; Priyanka Gogte; Richard Kaplan; Kevin C Chen; Eric Nudleman; Dilraj Grewal; Meenakashi Gupta; Jeremy Wolfe; Michael Klufas; Glenn Yiu; Iman Soltani-Bozchalooi; Parisa Emami-Naeini

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):223.

ARVO Annual Meeting Abstract June 2022

Clinical outcomes of retinal arterial macroaneurysms with vitreous hemorrhage managed with observation versus anti-VEGF versus pars plana vitrectomy

Sophia Shinsee Lam; Abtin Shahlaee; Mirataollah Salabati; Michael Klufas

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1747 – F0207.

ARVO Annual Meeting Abstract June 2022

Racial and Gender Disparities in Enrollment and Participation in Diabetic Macular Edema Clinical Trials in the United States

Ajay E. Kuriyan; Theo Bowe; Rebecca Russ Soares; Charles Huang; Rishi P Singh; M. Ali Ali Khan; Basil K Williams; Jayanth Sridhar; Allen Chiang; Michael Cohen; Michael Klufas; Omesh P Gupta; Yoshihiro Yonekawa; David Xu

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2505 – F0231.

ARVO Annual Meeting Abstract June 2022

Outcomes of Rhegmatogenous Retinal Detachment Repair in Patients with Nystagmus

Abtin Shahlaee; Mirataollah Salabati; Raziyeh Mahmoudzadeh; Michael Klufas

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3434 – F0334.

ARVO Annual Meeting Abstract June 2022

Rhegmatogenous Retinal Detachment Repair Clinical Outcomes in Pseudophakic Eyes with Multifocal versus Monofocal Lenses

Rachel Israilevich; Abtin Shahlaee; Mirataollah Salabati; Raziyeh Mahmoudzadeh; Taku Wakabayashi; Yoshihiro Yonekawa; Michael Klufas

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3435 – F0335.

ARVO Annual Meeting Abstract June 2021

Retinal Displacement Following Incisional Rhegmatogenous Retinal Detachment Repair

Raziyeh Mahmoudzadeh; Mirataollah Salabati; Yoshihiro Yonekawa; Ajay E Kuriyan; M.Ali Khan; Michael A. Klufas; Sunir J. Garg; Omesh Gupta; Carl Regillo; Michael N. Cohen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3084.

ARVO Annual Meeting Abstract July 2019

Clinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion

Turner D Wibbelsman; Daniel B Calem; Anthony Obeid; Phoebe L Mellen; Michelle A. Konkoly; Michael R. Velez; Kareem Sioufi; Durga S Borkar; Ravi Pandit; Michael A. Klufas; Jason Hsu; Carl Regillo; Allen C Ho; Omesh P Gupta; Marc J. Spirn

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4057.

ARVO Annual Meeting Abstract July 2019

Patients ultra-responsive to ranibizumab: rates of ≥4-step improvement in diabetic retinopathy severity in DRCR.net Protocol S

Michael A. Klufas; Allen Chiang; Lauren Hill; Min Tsuboi; Ivaylo Stoilov

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5358.

ARVO Annual Meeting Abstract July 2019

Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab

Jason Hsu; Anthony Obeid; Phoebe L Mellen; Turner D Wibbelsman; Michelle A. Konkoly; Michael R. Velez; Daniel B. Calem; Kareem Sioufi; Daniel Su; Philip Storey; Michael A. Klufas; Marc J. Spirn; Carl Regillo; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):80.

ARVO Annual Meeting Abstract July 2018

Experience and Outcomes of Pneumatic Retinopexy Performed by Vitreoretinal Fellows in the United States

Glenn Yiu; Parisa Emami-naeini; Jordan Deaner; Ferhina Ali; Priyanka Gogte; Richard Kaplan; Kevin Chen; Eric nudleman; Dilraj Singh Grewal; Meenakashi Gupta; Jeremy D. Wolfe; Michael Klufas

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1160.

ARVO Annual Meeting Abstract July 2018

Comparison of Residual Subfoveal Fluid by Intraoperative Optical Coherence Tomography After Macula Involving Rhegmatogenous Retinal Detachment Repair Using Direct Drainage, Drainage Retinotomy, or Perfluoro-n-Octane

Anthony Obeid; David Ehmann; Murtaza Adam; Sundeep Kasi; Michael Klufas; Jason Hsu; Sonia Mehta; Allen Chiang; Sunir Garg; Omesh Gupta

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4251.

ARVO Annual Meeting Abstract September 2016

A Comparison of Optical Coherence Tomography Angiography to Fluorescein Angiography for the Imaging of Type 1 Neovascularization

Maiko Inoue; Jesse J Jung; Chandra Bala; Talisa E de Carlo; Abtin Shahlaee; Michael A Klufas; Jay S Duker; Allen C Ho; Maddalena QUARANTA EL-MAFTOUHI; David Sarraf; K Bailey Freund

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

Articles July 2016

A Comparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 Neovascularization

PDF

Maiko Inoue; Jesse J. Jung; Chandrakumar Balaratnasingam; Kunal K. Dansingani; Elona Dhrami-Gavazi; Mihoko Suzuki; Talisa E. de Carlo; Abtin Shahlaee; Michael A. Klufas; Adil El Maftouhi; Jay S. Duker; Allen C. Ho; Maddalena Quaranta-El Maftouhi; David Sarraf; K. Bailey Freund; for the COFT-1 Study Group
TAGS: angiogram, diagnostic imaging, face, fluorescein angiography, neovascularization, pathologic, optical coherence tomography, eye
Invest. Ophthalmol. Vis. Sci.. 2016; 57(9):OCT314-OCT323. https://doi.org/10.1167/iovs.15-18900

ARVO Annual Meeting Abstract June 2015

Utility of Fluorescein Angiography for the Diagnosis and Management of Retinopathy of Prematurity (ROP)

Karyn Jonas; Samir Patel; Michael A Klufas; Michael Ryan; Mrinali Patel Gupta; Susan Ostmo; Audina M Berrocal; Maria Ana Martinez-Castellanos; Michael F Chiang; Robison Vernon Paul Chan

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):965.

ARVO Annual Meeting Abstract June 2015

Ultra-Widefield Imaging of Vitreoretinal Pathology in the Setting of the Boston Keratoprosthesis

Daniel L Kornberg; Nicolas A Yannuzzi; Michael A Klufas; Donald J D'Amico; Szilard Kiss

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3082.

ARVO Annual Meeting Abstract June 2015

Variable Results for Uveal Melanoma Specific Gene Expression Profile Prognostic Test in Choroidal Metastasis

Michael Adrian Klufas; Sujit Itty; Colin A McCannel; Ben J Glasgow; Christian Moreno; Tara A. McCannel

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4335.

ARVO Annual Meeting Abstract April 2014

Feasibility and Clinical Utility of Ultra-Widefield Indocyanine Green Angiography

Michael Klufas; Nicolas A Yannuzzi; Claudine E Pang; Sowmya Srinivas; Srinivas R Sadda; K Bailey Freund; Szilard Kiss

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):208.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Ultra-responders to faricimab: ≥4-step improvement in diabetic retinopathy severity in YOSEMITE/RHINE

Port Delivery System With Ranibizumab (PDS) in diabetic macular edema (DME): additional primary analysis results of the phase 3 Pagoda trial

Prevalence, Characteristics, and Outcomes of Retinal Detachment Associated with Toxoplasmosis Retinochoroiditis

Automated machine learning to predict anatomical outcomes in pneumatic retinopexy

Clinical outcomes of retinal arterial macroaneurysms with vitreous hemorrhage managed with observation versus anti-VEGF versus pars plana vitrectomy

Racial and Gender Disparities in Enrollment and Participation in Diabetic Macular Edema Clinical Trials in the United States

Outcomes of Rhegmatogenous Retinal Detachment Repair in Patients with Nystagmus

Rhegmatogenous Retinal Detachment Repair Clinical Outcomes in Pseudophakic Eyes with Multifocal versus Monofocal Lenses

Retinal Displacement Following Incisional Rhegmatogenous Retinal Detachment Repair

Clinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion

Patients ultra-responsive to ranibizumab: rates of ≥4-step improvement in diabetic retinopathy severity in DRCR.net Protocol S

Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab

Experience and Outcomes of Pneumatic Retinopexy Performed by Vitreoretinal Fellows in the United States

Comparison of Residual Subfoveal Fluid by Intraoperative Optical Coherence Tomography After Macula Involving Rhegmatogenous Retinal Detachment Repair Using Direct Drainage, Drainage Retinotomy, or Perfluoro-n-Octane

A Comparison of Optical Coherence Tomography Angiography to Fluorescein Angiography for the Imaging of Type 1 Neovascularization

A Comparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 Neovascularization

Utility of Fluorescein Angiography for the Diagnosis and Management of Retinopathy of Prematurity (ROP)

Ultra-Widefield Imaging of Vitreoretinal Pathology in the Setting of the Boston Keratoprosthesis

Variable Results for Uveal Melanoma Specific Gene Expression Profile Prognostic Test in Choroidal Metastasis

Feasibility and Clinical Utility of Ultra-Widefield Indocyanine Green Angiography

To View More...

You must be signed into an individual account to use this feature.